Why is there a need for Cellaria and its services in today's world?
Cellaria is developing and building more informative disease cell models to revolutionize and accelerate the search for cures. The two primary areas of focus are creating individualized (patient-derived) cancer cell models that are highly representative of the inVitro sample they come from, and utilizing stem cells to create differentiated cell types and models. Cellaria's products and services enable researchers to select promising compounds and ultimately identify the most effective therapeutics for each patient’s needs.
What do you believe makes Cellaria unique?
Cellaria's ability to creatively find highly-accurate alternatives to existing testing models (for instance, animal models) with inVitro human cell-based models, leads to more relevant drug response data. This facilitates the efficient and effective translation of preclinical research from models into human therapies while avoiding the false results often seen in animal models. All our models start with a patient-derived sample tissue specimen, and maintain the most relevant and translatable biology for patients, even with difficult-to-culture tumors, due to a successful combination of both factors profound expertise in creating the cell models and in-house-made media that provides fidelity of primary cells in growing heterogeneous culture of cells.
What particularly excites you about what Cellaria does?
I am excited to support a personalized patient-oriented research focus, that carries the potential to significantly improve drug development. For instance, patient-derived cancer cell lines allow testing and analysis of drug response when using applicable cancer treatments. This is because the most relevant and truly representative testing models are what allows us to reach relevant and truly representative end-points, which is the ultimate goal. Most potential new drugs fail when they reach the human testing stage, although these drugs all previously showed promise in drug responses based on animal testing. These failures not only increase cost, adding to the drug development process but often prolong the overall time in finding the treatments for patients whose life counts on the solution from the disease.
Why did you choose to work for Cellaria over other companies in the cell culture space?
Cellaria's vision inspired me. I chose to work for Cellaria because I wanted to empower research teams of different existing and newly evolving companies, striving to make a difference in the battle against diseases, to be aware of Cellaria and its innovative solutions. I am driven by the goal to introduce Cellaria to all the game changers in the Biotech field because inVitro human-based models, in my opinion, are invaluable in translating true results from bench to bedside.
Tell us a bit about your background and your journey to your current role:
My curious, adventurous, and challenge-taking personality led me to step into a Sales Development career where I tested different fields, such as, Oil and Gas, Energy, Logistics, and finally the Biotech field. Here is where I realized how much science and understanding of the capability of the human body's own immune system inspires me. As a Sales Dev Executive, I get to work with an outstanding team, have an opportunity to meet extraordinary professionals working every day to save someone's life, and last, but not least, this role allows me to look for the research teams, that when combined with Cellaria's innovative approach, could benefit the search for a cure and improve the drug efficacy leading to saving lives. Every day at work I am thinking that we have an opportunity to solve one more piece of the puzzle. It is very inspiring for a science fan like me.
What is your responsibility at Cellaria?
As a Sales Development Executive my primary focus is to grow awareness of Cellaria and develop the market for our unique technologies in Oncology, Cell Biology, Proteomics, and related fields. My responsibilities include managing customer relations and associated accounts, introducing those to our scientific team, and incorporating the custom services and products related to custom human patient models into the workflow of the drug development process for industrial clients.